Shopping Cart
- Remove All
- Your shopping cart is currently empty
EF24 (3,5-Bis[(2-fluorophenyl)Methylene]-4-piperidinone) treatment increases the levels of activated caspase 3 and 9, and decreases the phosphorylated forms of MEK1 and ERK. EF24 shows potent anti-tumor activity in oral squamous cell carcinoma (OSCC) via deactivation of the MAPK/ERK signaling pathway.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $34 | In Stock | |
5 mg | $77 | In Stock | |
10 mg | $135 | In Stock | |
25 mg | $247 | In Stock | |
50 mg | $372 | In Stock | |
100 mg | $562 | In Stock | |
500 mg | $1,190 | In Stock | |
1 g | $1,590 | In Stock | |
1 mL x 10 mM (in DMSO) | $85 | In Stock |
Description | EF24 (3,5-Bis[(2-fluorophenyl)Methylene]-4-piperidinone) treatment increases the levels of activated caspase 3 and 9, and decreases the phosphorylated forms of MEK1 and ERK. EF24 shows potent anti-tumor activity in oral squamous cell carcinoma (OSCC) via deactivation of the MAPK/ERK signaling pathway. |
Alias | EF-24, EF 24, 3,5-Bis[(2-fluorophenyl)Methylene]-4-piperidinone |
Molecular Weight | 311.33 |
Formula | C19H15F2NO |
Cas No. | 342808-40-6 |
Smiles | Fc1ccccc1\C=C1/CNC\C(=C/c2ccccc2F)C1=O |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 25 mg/mL (80.3 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.